On July 29, 2024 AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options, and improving quality of life for patients, reported that its management is scheduled to participate in the following upcoming investor conferences (Press release, AngioDynamics, JUL 29, 2024, View Source [SID1234645142]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

9th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference
Date: August 12, 2024

Canaccord Genuity 44th Annual Growth Conference
Presentation: August 13, 2024 at 10:00am

A live webcast of the presentation will be accessible through the "Investors" section of the Company’s website at www.angiodynamics.com.